Automated Author Profile

Blaauw, Renee

Current S-Index

0.7

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.3

Average Dataset Index per dataset

Total Datasets

2

Total datasets for this author

Average FAIR Score

13.5%

Average FAIR Score per dataset

Total Citations

0

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Additional file 2 of The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis

Additional file 2: Supplementary Table 1. Quality assessment of included studies according to the Jadad scale. Supplementary Table 2. Risk of bias assessment of individual studies included. Supplementary Table 3. Frequency of outcome assessment and follow-up duration. Supplementary Table 4a. Outcome measurement at end point by allocation. Supplementary Table 4b. Outcome measurement at end point by allocation. Supplementary Table 4c. Outcome measurement at end point by allocation. Supplementary Figure 1. Funnel plot for aggregate patient data meta-analysis of sputum smear conversion rate conversion in vitamin D supplemented randomized controlled trials. Supplementary Figure 2. Funnel plot for aggregate patient data meta-analysis of sputum smear conversion rate in other anti-inflammatory HDT agents supplemented randomized controlled trials.

Authors

  • Hayford, Frank Ekow Atta ;
  • Dolman, Robin Claire ;
  • Blaauw, Renee ;
  • Arista Nienaber ;
  • Smuts, Cornelius Mattheus ;
  • Malan, Linda ;
  • Ricci, Cristian
0 Citations0 Mentions13% FAIR0.3 Dataset Index
10.6084/m9.figshare.12870412.v1January 2020

Additional file 2 of The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis

Additional file 2: Supplementary Table 1. Quality assessment of included studies according to the Jadad scale. Supplementary Table 2. Risk of bias assessment of individual studies included. Supplementary Table 3. Frequency of outcome assessment and follow-up duration. Supplementary Table 4a. Outcome measurement at end point by allocation. Supplementary Table 4b. Outcome measurement at end point by allocation. Supplementary Table 4c. Outcome measurement at end point by allocation. Supplementary Figure 1. Funnel plot for aggregate patient data meta-analysis of sputum smear conversion rate conversion in vitamin D supplemented randomized controlled trials. Supplementary Figure 2. Funnel plot for aggregate patient data meta-analysis of sputum smear conversion rate in other anti-inflammatory HDT agents supplemented randomized controlled trials.

Authors

  • Hayford, Frank Ekow Atta ;
  • Dolman, Robin Claire ;
  • Blaauw, Renee ;
  • Arista Nienaber ;
  • Smuts, Cornelius Mattheus ;
  • Malan, Linda ;
  • Ricci, Cristian
0 Citations0 Mentions13% FAIR0.3 Dataset Index
10.6084/m9.figshare.12870412January 2020